Trial Profile
Utilization of Thromboelastography to Monitor Rivaroxaban Activity in Trauma and Emergency Surgery Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Blood coagulation disorders; Venous thromboembolism
- Focus Therapeutic Use
- 06 Nov 2019 Status changed from active, no longer recruiting to completed.
- 22 Apr 2019 Planned End Date changed from 1 Mar 2019 to 1 Sep 2019.
- 07 Sep 2018 Status changed from recruiting to active, no longer recruiting.